Skip to content
Screener

Baxter International BAX Medical Products & Therapies — Goodwill

Other segment segments

Healthcare Systems & Technologies
$3.08B-13.4%
Pharmaceuticals
$569M+2.2%

Similar metrics at other companies

Gentherm logo
THRMMedical — Goodwill
$28.09M+1.5%
Welltower logo
WELLOutpatient Medical — Goodwill
$68.32M0.0%
Healthpeak Properties logo
DOCOutpatient medical — Goodwill
$64.68M0.0%
Becton, Dickinson and Company logo
BDXMedical Essentials — Goodwill
$7.01B—
Novanta logo
NOVTMedical Solutions — Goodwill
$316.18M-1.5%
Bausch Health Companies logo
BHCSolta Medical — Goodwill
$137M+19.1%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%—
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0×0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
(in millions)Medical Products & TherapiesHealthcare Systems & TechnologiesPharmaceuticalsTotal
Balance as of December 31, 2025$1,265$3,087$577$4,929
Currency translation(17)(5)(8)(30)
Balance as of March 31, 2026$1,248$3,082$569$4,899

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's medical products & therapies — goodwill?
Baxter International (BAX) reported medical products & therapies — goodwill of $1.25B in Q1 2026.
How has Baxter International's medical products & therapies — goodwill changed year-over-year?
Baxter International's medical products & therapies — goodwill increased by 2.0% year-over-year, from $1.22B to $1.25B.
What does medical products & therapies — goodwill mean?
Represents the intangible asset value recorded when the Medical Products & Therapies segment acquired other businesses for a price exceeding the fair value of their net identifiable assets. It reflects the premium paid for brand reputation, customer relationships, and synergies within this specific business unit.

Ask your AI about Baxter International's medical products & therapies — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude